- Home
- BODI vs CCEL Comparison
BODI vs CCEL Comparison
Compare BODI & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- CCEL
- Stock Information
- Founded
- BODI 1998
- CCEL 1989
- Country
- BODI United States
- CCEL United States
- Employees
- BODI N/A
- CCEL N/A
- Industry
- BODI Industrial Machinery/Components
- CCEL Managed Health Care
- Sector
- BODI Industrials
- CCEL Health Care
- Exchange
- BODI Nasdaq
- CCEL Nasdaq
- Market Cap
- BODI 49.0M
- CCEL 51.9M
- IPO Year
- BODI N/A
- CCEL 1997
- Fundamental
- Price
- BODI $6.25
- CCEL $6.35
- Analyst Decision
- BODI Strong Buy
- CCEL Strong Buy
- Analyst Count
- BODI 3
- CCEL 1
- Target Price
- BODI $10.67
- CCEL $8.50
- AVG Volume (30 Days)
- BODI 13.5K
- CCEL 15.1K
- Earning Date
- BODI 05-05-2025
- CCEL 04-14-2025
- Dividend Yield
- BODI N/A
- CCEL 3.92%
- EPS Growth
- BODI N/A
- CCEL N/A
- EPS
- BODI N/A
- CCEL 0.05
- Revenue
- BODI $418,796,000.00
- CCEL $31,986,106.00
- Revenue This Year
- BODI N/A
- CCEL $2.21
- Revenue Next Year
- BODI $1.13
- CCEL $0.98
- P/E Ratio
- BODI N/A
- CCEL $129.01
- Revenue Growth
- BODI N/A
- CCEL 2.05
- 52 Week Low
- BODI $5.14
- CCEL $5.75
- 52 Week High
- BODI $10.80
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- BODI 38.68
- CCEL 41.09
- Support Level
- BODI $6.61
- CCEL $6.13
- Resistance Level
- BODI $7.55
- CCEL $6.65
- Average True Range (ATR)
- BODI 0.67
- CCEL 0.37
- MACD
- BODI -0.09
- CCEL 0.04
- Stochastic Oscillator
- BODI 0.00
- CCEL 42.86
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.